Pharmaceutical company outsource the various processes of Pharmacovigilance to a service provider to carry out the business process. For every active partner, the PV Agreement also called as Safety Data Exchange Agreement becomes a mandate. The various phases of establishing the executive agreement is an extended process involving multiple stakeholders resulting in the scattered information passed through various channels.
In recent years with the increasing number of programs has increased the number of active PV agreements. The PV office and PV QA team are in turmoil with source truth and maintenance of the PV Agreements. The PV team do not have oversight over the partner performance on various aspects.
How Do we Deliver
Compier Agreements (SDEA) module is a component of our Compier platform. It can be deployed on its own or in combination with other modules of the platform. Our technology platform and subject matter expertise enable you with a comprehensive solution to digitalize the PV Agreement (SDEA) and track the Vendor performance on Timelines and Quality ensuring process and performance optimization
New Insights
How to Proactively Prevent Clinical Trial Protocol Deviations and Protocol Violations
Understanding the Importance of a Clinical Trial Protocol The fundamental objective of a clinical trial protocol is to provide common scientific guidance on how to conduct the clinical study in a regulatory-compliant manner and gather data that will ultimately provide answers on the safety and efficacy of the investigational medicinal product. The Guidelines for Good [...]
Food & Nutraceuticals: How Companies can Prove Health Value with Clinical Trials
What are Food and Nutraceuticals? ‘Nutraceuticals’ is a composite term of ‘nutrition’ and ‘pharmaceutical’. They are a blend of products that possess both nutritional as well as medicinal value. They are designed to improve physical health, boost immunity, and deal with stress and increase longevity. Nutraceutical products play a significant role in maintaining normal physiological [...]
Best Practices for Signal Management in Pharmacovigilance
Pharmacovigilance involves the collection, detection, assessment, and monitoring of data on Adverse Drug Reactions (ADRs) which must be evaluated to derive vital safety information. Signal detection involves monitoring the adverse reaction data for patterns that suggest new safety information. Safety signals can be detected from an extensive range of sources, such as spontaneous reports, clinical [...]